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In a retrospective study we compared 500 known cancer with respect to their visibility in the different projections. Visualized in all 3 projections 438 87.6% m-i and 45 ~ pro~ections 14 2.8% o-c and 45 ~ projections 8 1.6% c-c and m-i projections 7 1.4% Only in the 45 ~ projection 4 0.8% Only in the m-I projection 2 0.4% Only in the c-c projection 4 0.8% We found that 95,4% of all cancers could be diagnosed by mammography. Of these, 98,6% could be seen in the 45 ~ projection. In a prospective study, we looked at another 500 mammographies.
This time only considering the 45 ~ projection.
We then compared these results ( 45 ~ with those of the radiologist (all 3 projections).
Insus In breast cancer the prognosis is influenced decisively by the size of tumor and by whether metastases have spread to the axillary lymph nodes. To diagnose tumors that are less than i cm in size clinical examinfation and palpation are rather crude procedures with limited value. In order to solve those problems with nonpalpable breast lesions the method of SFNB was developed in Sweden in 1977. Our experiences with this Mammotest-system exist since 1983. To date 54S patients have been referred. In 5S cases (9.8 %) the biopsy could not be performed for methodological reasons. Of 490 patients, S8.2 % (n=187) were subjected to SFNB and then operated on after preoperative stereotaxic ehromoloealization. Taken together, 78.6 % (n=147) of these cases showed benign histologies.
Including one false negative cytological report, malignancy was found in 21.4 % (n:40). Morphometrically, gO of these tumors were smaller than 5 mm. One control group (SI.6 %) was subjected to repeated biopsies and mammography. A second control group ($2.8 %) was followed up only mammographically. In both groups the findings were unchanged after two years. The statistical results (cytology vs. histological examination, Chi-square-test) of 187 patients showed a sensitivity of 97.5 % and a specifity of 95.2 %. This is equivalent to the standard achieved in the diagnosis of cervical cancer, which is generally considered optimal. It follows from this that SFNB is a method of high validity, easy to perform, not very timeconsuming, and well tolerated by all patients. It is a valuable addition to mammography. 
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